Bayer and Kumquat Biosciences have partnered on a promising new cancer drug, with Kumquat leading early trials and Bayer managing the market launch.
Editor’s Note: This collaboration could bring innovative treatments to market, potentially improving outcomes for cancer patients and showcasing advancements in drug development.
— Curated by the World Pulse Now AI Editorial System
A charity warns that many men diagnosed with low-risk prostate cancer are receiving unnecessary treatments that could lead to serious side effects. Instead, monitoring options could be a better choice.
Editor’s Note: This story highlights an important conversation about the balance between effective cancer treatment and the risks of over-treatment, which can significantly impact patients' quality of life.
This health care roundup offers insights on major players like Novartis, Eli Lilly, and Dexcom, highlighting current market trends and news.
Editor’s Note: Staying updated on major health care companies helps investors and consumers understand market dynamics and potential impacts on treatment and innovation.
More babies are being introduced to meat-heavy diets, munching on items like lamb and pork rinds. Experts are worried about the nutritional implications of this trend.
Editor’s Note: This story highlights a controversial dietary trend for young children, raising questions about their health and nutrition as parents explore unconventional feeding practices.
This article explores the safety of melatonin as a sleep aid and discusses the controversial practice of eating placenta, weighing potential benefits and risks.
Editor’s Note: Understanding sleep aids and dietary choices like placentophagy is important for making informed health decisions that impact wellbeing.